(3-Bromophenyl)(4-(pyrrolidin-1-yl)piperidin-1-yl)methanone

SynDRA canonical compound SYN1353955 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	L3MBTL1 \| L3MBTL3
Mechanism of action	MBT inhibitor

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

L3MBTL3
L3MBTL1

Cross-references

PubChem CID: 61041645
ChEMBL: CHEMBL2426369

Synonyms

UNC 926
UNC926
UNC-926 free base
(3-bromophenyl)-(4-pyrrolidin-1-ylpiperidin-1-yl)methanone
UNC926 free base
orb1303310
SCHEMBL19730382
UNC926?
GLXC-03121
EX-A4232
JXB13610
BDBM50440618
s5262
AKOS010271344
CCG-267876
CS-6947
NCGC00379146-01
BS-14519
DA-58886
HY-16510
UNC926, >=98% (HPLC)
T4012
C71583
F521456
(3-bromophenyl)-(4-pyrrolidin-1-yl-1-piperidyl)methanone
UNC926,1184136-10-4, UNC926,UNC-926,UNC 926

Look up (3-Bromophenyl)(4-(pyrrolidin-1-yl)piperidin-1-yl)methanone in the interactive SynDRA portal →